Idera Pharmaceuticals reported $5.97M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbott ABT:US $ 8383M 448M
Aceto ACET:US 17.14M 1.5M
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Amgen AMGN:US $ 4.33B 1.37B
Biogen BIIB:US $ 1984.9M 304.4M
Biomarin Pharmaceutical BMRN:US $ 461.96M 28.06M
Cytrx CYTR:US 1.53M 351.4K
Dynavax Technologies DVAX:US $ 92.2M 43.38M
Eli Lilly And LLY:US $ 5296.8M 39.9M
Gilead Sciences GILD:US $ 3579M 392M
GlaxoSmithKline GSK:LN 7.14B 722M
Idera Pharmaceuticals IDRA:US $ 5.97M 1.59M
Merk MRK:US $ 8328M 1460M
Mirati Therapeutics MRTX:US $ 151.29M 12.89M
Nektar Therapeutics NKTR:US $ 138.52M 18K
Pfizer PFE:US $ 16447M 3384M
Sarepta Therapeutics SRPT:US $ 228.35M 103.31M
Seattle Genetics SGEN:US $ 722.02M 243.94M
Ultragenyx Pharmaceutical RARE:US $ 171.48M 1.72M
X T L Biopharmaceuticals XTLB:US 257K 40K